Skip to content
OpenCapital
Get started

Bio-Techne TECH Diagnostics And Genomics — Goodwill

Discontinued — last reported Q4 '24

Other segment segments

Diagnostics And Spatial Biology
$553.62M+1.1%
Protein Sciences
$424.18M+0.7%

Similar metrics at other companies

Agilent Technologies logo
ADiagnostics and Genomics — Goodwill
$2.64B+24.1%
Labcorp Holdings logo
LHDiagnostics — Goodwill
$5.61B—
Agilent Technologies logo
ADiagnosticsandgenomicssolutions — Goodwill Transfers
$11.25M—
Agilent Technologies logo
ADiagnostics and Genomics — Goodwill, Written off Related to Sale of Business Unit
$3.25M—
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Goodwill
$3B-0.1%
Bio-Rad Laboratories logo
BIO.BClinical Diagnostics — Goodwill, Acquired During Period
——

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bio-Techne’s 10-K, filed August 22, 2024, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's diagnostics and genomics — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's diagnostics and genomics — goodwill?
Bio-Techne (TECH) reported diagnostics and genomics — goodwill of $549.21M in Q2 2024.
How has Bio-Techne's diagnostics and genomics — goodwill changed year-over-year?
Bio-Techne's diagnostics and genomics — goodwill increased by 23.2% year-over-year, from $445.71M to $549.21M.
What is the long-term trend for Bio-Techne's diagnostics and genomics — goodwill?
Over 3 years (2021 to 2024), Bio-Techne's diagnostics and genomics — goodwill has grown at a 13.1% compound annual growth rate (CAGR), from $1.52B to $2.2B.
What does diagnostics and genomics — goodwill mean?
The value of intangible assets like brand and synergy from acquisitions in the Diagnostics and Genomics segment.
How do you interpret diagnostics and genomics — goodwill?
Growth in goodwill indicates recent M&A activity, while sudden decreases suggest potential impairment charges.
How does diagnostics and genomics — goodwill compare across companies?
Standard balance sheet item for companies that grow through acquisition in the diagnostics market.